These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

620 related articles for article (PubMed ID: 21358173)

  • 1. Observed and predicted total pubertal growth during treatment with growth hormone in adolescents with idiopathic growth hormone deficiency, Turner syndrome, short stature, born small for gestational age and idiopathic short stature: KIGS analysis and review.
    Ranke MB; Lindberg A
    Horm Res Paediatr; 2011; 75(6):423-32. PubMed ID: 21358173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone age progression during the first year of growth hormone therapy in pre-pubertal children with idiopathic growth hormone deficiency, Turner syndrome or idiopathic short stature, and in short children born small for gestational age: analysis of data from KIGS (Pfizer International Growth Database).
    Darendeliler F; Ranke MB; Bakker B; Lindberg A; Cowell CT; Albertsson-Wikland K; Reiter EO; Price DA
    Horm Res; 2005; 63(1):40-7. PubMed ID: 15627781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accurate long-term prediction of height during the first four years of growth hormone treatment in prepubertal children with growth hormone deficiency or Turner Syndrome.
    Ranke MB; Lindberg A; Brosz M; Kaspers S; Loftus J; Wollmann H; Kołtowska-Haggstrom M; Roelants M
    Horm Res Paediatr; 2012; 78(1):8-17. PubMed ID: 22832697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The mathematical model for total pubertal growth in idiopathic growth hormone (GH) deficiency suggests a moderate role of GH dose.
    Ranke MB; Lindberg A; Martin DD; Bakker B; Wilton P; Albertsson-Wikland K; Cowell CT; Price DA; Reiter EO
    J Clin Endocrinol Metab; 2003 Oct; 88(10):4748-53. PubMed ID: 14557450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of growth hormone treatment on children with idiopathic short stature (ISS), idiopathic growth hormone deficiency (IGHD), small for gestational age (SGA) and Turner syndrome (TS) in a tertiary care center.
    Al Shaikh A; Daftardar H; Alghamdi AA; Jamjoom M; Awidah S; Ahmed ME; Soliman AT
    Acta Biomed; 2020 Mar; 91(1):29-40. PubMed ID: 32191651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors determining pubertal growth and final height in growth hormone treatment of idiopathic growth hormone deficiency. Analysis of 195 Patients of the Kabi Pharmacia International Growth Study.
    Ranke MB; Price DA; Albertsson-Wikland K; Maes M; Lindberg A
    Horm Res; 1997; 48(2):62-71. PubMed ID: 9251922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Growth Hormone treatment in children with Growth Hormone deficiency, idiopathic short stature, SHOX gene mutation, small for gestational age and Turner syndrome].
    Griffero González M; González Navarrete D; Tolosa Navarro F; López Cuevas P; Rodríguez Convertino F; Román Reyes R
    Andes Pediatr; 2024 Apr; 95(2):151-158. PubMed ID: 38801362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin-like growth factor I and growth responses during the first year of growth hormone treatment in KIGS patients with idiopathic growth hormone deficiency, acquired growth hormone deficiency, turner syndrome and born small for gestational age.
    Cutfield WS; Lundgren F
    Horm Res; 2009 Jan; 71 Suppl 1():39-45. PubMed ID: 19153504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Observed and predicted growth responses in prepubertal children with growth disorders: guidance of growth hormone treatment by empirical variables.
    Ranke MB; Lindberg A;
    J Clin Endocrinol Metab; 2010 Mar; 95(3):1229-37. PubMed ID: 20097713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of growth hormone therapy and puberty on bone and body composition in children with idiopathic short stature and growth hormone deficiency.
    Högler W; Briody J; Moore B; Lu PW; Cowell CT
    Bone; 2005 Nov; 37(5):642-50. PubMed ID: 16139578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is the growth outcome of children with idiopathic short stature and isolated growth hormone deficiency following treatment with growth hormone and a luteinizing hormone-releasing hormone agonist superior to that obtained by GH alone?
    Colmenares A; González L; Gunczler P; Lanes R
    J Pediatr Endocrinol Metab; 2012; 25(7-8):651-7. PubMed ID: 23155689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased response, but lower responsiveness, to growth hormone (GH) in very young children (aged 0-3 years) with idiopathic GH Deficiency: analysis of data from KIGS.
    Ranke MB; Lindberg A; Albertsson-Wikland K; Wilton P; Price DA; Reiter EO
    J Clin Endocrinol Metab; 2005 Apr; 90(4):1966-71. PubMed ID: 15634724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The d3-growth hormone (GH) receptor polymorphism is associated with increased responsiveness to GH in Turner syndrome and short small-for-gestational-age children.
    Binder G; Baur F; Schweizer R; Ranke MB
    J Clin Endocrinol Metab; 2006 Feb; 91(2):659-64. PubMed ID: 16291706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response to growth hormone treatment in isolated growth hormone deficiency versus multiple pituitary hormone deficiency.
    Darendeliler F; Lindberg A; Wilton P
    Horm Res Paediatr; 2011; 76 Suppl 1():42-6. PubMed ID: 21778748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is growth hormone treatment in children associated with weight gain?--longitudinal analysis of KIGS data.
    Reinehr T; Lindberg A; Koltowska-Häggström M; Ranke M
    Clin Endocrinol (Oxf); 2014 Nov; 81(5):721-6. PubMed ID: 24750131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Total pubertal growth and markers of puberty onset in adolescents with GHD: comparison between mathematical growth analysis and pubertal staging methods.
    Martin DD; Hauspie RC; Ranke MB
    Horm Res; 2005; 63(2):95-101. PubMed ID: 15735371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Major determinants of height development in Turner syndrome (TS) patients treated with GH: analysis of 987 patients from KIGS.
    Ranke MB; Lindberg A; Ferrández Longás A; Darendeliler F; Albertsson-Wikland K; Dunger D; Cutfield WS; Tauber M; Wilton P; Wollmann HA; Reiter EO;
    Pediatr Res; 2007 Jan; 61(1):105-10. PubMed ID: 17211150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction models for short children born small for gestational age (SGA) covering the total growth phase. Analyses based on data from KIGS (Pfizer International Growth Database).
    Ranke MB; Lindberg A;
    BMC Med Inform Decis Mak; 2011 Jun; 11():38. PubMed ID: 21627853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attaining genetic height potential: Analysis of height outcomes from the ANSWER Program in children treated with growth hormone over 5 years.
    Ross JL; Lee PA; Gut R; Germak J
    Growth Horm IGF Res; 2015 Dec; 25(6):286-93. PubMed ID: 26363846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth response, near-adult height, and patterns of growth and puberty in patients with noonan syndrome treated with growth hormone.
    Romano AA; Dana K; Bakker B; Davis DA; Hunold JJ; Jacobs J; Lippe B
    J Clin Endocrinol Metab; 2009 Jul; 94(7):2338-44. PubMed ID: 19401366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.